» Articles » PMID: 39487454

Patient-centered Care in Pulmonary Fibrosis: Access, Anticipate, and Act

Overview
Journal Respir Res
Specialty Pulmonary Medicine
Date 2024 Nov 2
PMID 39487454
Authors
Affiliations
Soon will be listed here.
Abstract

Comprehensive care integrates individual patient needs and is highly valued for patients with pulmonary fibrosis (PF). The importance of a patient-centered care approach is rooted in the unpredictable progressiveness of the disease course in PF. The respiratory impairment associated with PF has a major impact on the quality of life for both patients and their caregivers. We believe that prioritizing patient preferences could improve the shared decision making process and may ultimately lead to better health outcomes. Despite the growing emphasis for this approach, it remains challenging to adopt it in clinical practice. In this review, we propose the comprehensive Triple A Care Model, consisting of the domains Access, Anticipate, and Act, which emphasizes core elements of patient-centered care for patients with PF. We will provide an overview of the unmet needs in care for patients with PF and elaborate on the current methods for delivering patient-centered care. The latest insights into symptom management and supportive measures and several approaches to improving access to care are discussed, in line with the most recent guidelines.

References
1.
Bargagli E, Di Masi M, Perruzza M, Vietri L, Bergantini L, Torricelli E . The pathogenetic mechanisms of cough in idiopathic pulmonary fibrosis. Intern Emerg Med. 2018; 14(1):39-43. DOI: 10.1007/s11739-018-1960-5. View

2.
Khanna D, Denton C, Jahreis A, van Laar J, Frech T, Anderson M . Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial. Lancet. 2016; 387(10038):2630-2640. DOI: 10.1016/S0140-6736(16)00232-4. View

3.
Caminati A, Lonati C, Cassandro R, Elia D, Pelosi G, Torre O . Comorbidities in idiopathic pulmonary fibrosis: an underestimated issue. Eur Respir Rev. 2019; 28(153). PMC: 9488913. DOI: 10.1183/16000617.0044-2019. View

4.
Khor Y, Saravanan K, Holland A, Lee J, Ryerson C, McDonald C . A mixed-methods pilot study of handheld fan for breathlessness in interstitial lung disease. Sci Rep. 2021; 11(1):6874. PMC: 7994303. DOI: 10.1038/s41598-021-86326-8. View

5.
Wijsenbeek M, Swigris J, Inoue Y, Kreuter M, Maher T, Suda T . Effects of nintedanib on symptoms in patients with progressive pulmonary fibrosis. Eur Respir J. 2023; 63(2). PMC: 10831140. DOI: 10.1183/13993003.00752-2023. View